tb500

TB500 is a shortened form of thymosin beta-4 that is discussed as a potential tissue-repair peptide, but its effects in humans remain uncertain. 1

• What it is: TB500 is a laboratory-made, shortened version of thymosin beta-4, a peptide the body produces. 2
• Potential repair role: Thymosin beta-4 is described as supporting the growth and movement of cells involved in tissue repair, including stem-cell proliferation and extracellular-matrix formation. 3
• Evidence limits: Much of the supporting research is from animal studies. People report benefits, but without clinical trials it is not known whether or how TB500 works in humans. 4
• Compared with BPC-157: BPC-157 is framed mainly around angiogenesis—forming new blood vessels—whereas thymosin beta-4/TB500 is described as supporting cellular repair rather than acting through growth-hormone pathways. 5
• Caution: The discussion emphasizes that human effects are uncertain; TB500 should not be treated as a proven therapy. 6